Anavex Life Sciences Announces Participation at Upcoming Worldwide National Institutes of Health (NIH) Panel at Rare Disease Day
Rare Disease Day at NIH will be held virtually on Monday, March 1, 2021, from 10:30 a.m. to 5:30 p.m. EST
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics
for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today
announced that its President and Chief Executive Officer, Christopher U. Missling, PhD, will join the panel, “Industry and Advocacy Collaborations ─ Making it a Win-Win”, at the National
Institutes of Health (NIH) virtual Rare Disease Day event on Monday, March 1st at 11:35 a.m. EST. There will be a live Q&A following the panel discussion.
Rare Disease Day takes place every year on the last day of February, with several international events extending into March. The event at the NIH is sponsored by the National Center for Advancing Translational Sciences and the NIH Clinical Center. Rare Disease Day at NIH aims to raise awareness about rare diseases, challenges and research underway. The event brings together all stakeholders involved in advancing research and therapeutic development for rare diseases and includes patients, rare disease families, patient advocacy professionals, healthcare providers, academic researchers, members of the biopharmaceutical industry, and government representatives.
Rare Disease Day at NIH will be held virtually on Monday, March 1st, 2021, from 10:30 a.m. to 5:30 p.m. EST. This year’s event will feature interactive panel discussions, rare stories through TED-style talks and more. The event is free and open to the public, including patients, patient advocates, health care providers, researchers, trainees, students, industry representatives and government employees.
Click here to register or to learn more about the event.
About Rare Disease Day at NIH
Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and NIH research collaborations underway to address scientific challenges and to advance new
The goals of Rare Disease Day at NIH are to:
- Demonstrate the NIH commitment to helping people with rare diseases through research.
- Highlight NIH-supported rare diseases research and the development of diagnostics and treatments.
- Initiate a mutually beneficial dialogue among public and private researchers, patients, patient advocates and policymakers.
- Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts.
- Put a face on rare diseases by sharing stories of patients, their families and their communities.
Anavex Life Sciences Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de